Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4341 studies found for:    Open Studies | "Brain Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Brain Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Lactulose for the Prevention of Hepatic Encephalopathy in Cirrhotic Patients With Upper Gastrointestinal Hemorrhage
Conditions: Hepatocerebral Encephalopathy;   Portal-Systemic Encephalopathy;   Encephalopathy, Hepatic;   Encephalopathy, Hepatocerebral
Interventions: Drug: Lactulose;   Drug: Placebo
2 Recruiting Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)
Conditions: Acute Episode of Overt Hepatic Encephalopathy;   Hepatic Encephalopathy
Interventions: Drug: ornithine phenylacetate;   Drug: placebo intravenous infusion
3 Unknown  The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy
Conditions: Hepatic Encephalopathy;   Hepatitis C;   Liver Cirrhosis
Intervention: Drug: Rifaximin (drug)
4 Unknown  RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial
Condition: Hepatic Encephalopathy
Intervention: Drug: Rifaximin alone, Rifaximin combined with Lactulose
5 Unknown  The Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: Placebo;   Drug: Rifaximin
6 Recruiting Preemie Hypothermia for Neonatal Encephalopathy
Conditions: Infant, Newborn;   Hypoxia, Brain;   Hypoxia-Ischemia, Brain;   Encephalopathy, Hypoxic-Ischemic;   Hypoxic-Ischemic Encephalopathy;   Ischemic-Hypoxic Encephalopathy
Interventions: Device: Hypothermia;   Procedure: Normothermic Control
7 Recruiting Metformin Experience on Minimal Hepatic Encephalopathy
Conditions: Liver Cirrhosis;   Hepatic Encephalopathy
Interventions: Drug: Metformin;   Drug: Placebo
8 Recruiting The Effects of Nitazoxanide in Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: Nitazoxanide;   Drug: Oral lactulose;   Drug: Metronidazole;   Drug: Rifaximine
9 Recruiting Autologous Cord Blood Cell Therapy for Neonatal Encephalopathy
Conditions: Neonatal Encephalopathy;   Hypoxic-ischemic Encephalopathy
Intervention: Other: Autologous umbilical cord blood cells
10 Unknown  Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis
Condition: Hepatic Encephalopathy
Interventions: Drug: Lactulose;   Drug: Probiotics(VSL#3)
11 Recruiting Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS
Conditions: Hepatic Encephalopathy;   Liver Cirrhosis
Interventions: Drug: Flumazenil;   Drug: Placebo
12 Unknown  Primary Prophylaxis of Hepatic Encephalopathy in Patients With Cirrhosis
Condition: Hepatic Encephalopathy
Intervention: Drug: Lactulose
13 Recruiting L-ornithine L-aspartate in Overt Hepatic Encephalopathy
Conditions: Cirrhosis of Liver;   Hepatic Encephalopathy
Interventions: Drug: L-ornithine L-aspartate;   Drug: Placebo
14 Unknown  A Nutritional Approach to Minimal Hepatic Encephalopathy
Condition: Minimal Hepatic Encephalopathy
Intervention: Other: Nutritional Intervention
15 Unknown  Efficacy of Combined Oral L-Ornithine-L-Aspartate and Lactulose in Patients With Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: L-ornithine-L-aspartate and lactulose;   Drug: placebo and lactulose
16 Unknown  ETOS: Minimal Hepatic Encephalopathy in Childhood and Young Adult: epidemiOlogical Study and Pilot Interventional Study
Condition: Hepatic Encephalopathy
Intervention: Dietary Supplement: probiotic VSL#3
17 Unknown  Randomised Controlled Trial of Mechanistic Effects of Rifaximin in Cirrhosis and Chronic Hepatic Encephalopathy
Conditions: Liver Cirrhosis;   Hepatic Encephalopathy.
Intervention: Drug: Rifaximin-α
18 Unknown  Efficacy Study of Hypothermia Plus Magnesium Sulphate(MgSO4) in the Management of Term and Near Term Babies With Hypoxic Ischemic Encephalopathy
Conditions: Severe Hypoxic Ischemic Encephalopathy;   Moderate Hypoxic Ischemic Encephalopathy
Interventions: Drug: Magnesium Sulphate;   Drug: Placebo
19 Recruiting Nitazoxanide Plus Lactulose Versus Lactulose Alone Treatment of Hepatic Encephalopathy
Condition: Encephalopathy, Hepatic
Interventions: Drug: Nitazoxanide;   Drug: Lactulose
20 Recruiting Albumin Infusion Effects in Mortality in Patients With Cirrhosis and Hepatic Encephalopathy
Conditions: Hepatic Encephalopathy;   Cirrhosis
Interventions: Drug: Human albumin;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years